Supplementary Table S5. Distribution of clinical and biomarker-related characteristics between Methylation Hypoxia High vs Low in the validation cohort (DKTK-ROG)</p
Clarifying the epigenetic regulation of tumor-related genes (TRGs) can provide insights into the mec...
<p>(A) Kaplan-Meier survival plots: (i) HPV (+) HNSCC tumors showing better survival compared to HPV...
PurposeThe hypoxic tumor microenvironment was reported to be involved in different tumorigenesis mec...
Supplementary Table S3. Distribution of clinical and biomarker-related characteristics between Methy...
Supplementary Table S7. Distribution of clinical and biomarker-related characteristics between Methy...
Supplementary Table S1. Multivariate Analysis for the Hypoxia-M and Brooks signature.</p
Supplementary Table S2. Treatment Information for the validation cohort (n=88, DKTK-ROG)</p
Supplementary Table S6. Contingency Table of Hypoxia-M and CD8-immunohistochemistry (IHC) staining f...
Supplementary Table S4. Correlations with CIBERSORT immune signature expressions in the TCGA-HNSCC c...
Supplementary Figure S3. (Top) Hypoxia-M V2 is associated with decreased OS in the TCGApancancer coh...
Supplementary Figure S2. (Top) Hypoxia-M V2 is prognostic in the DKTK-ROG cohort. Patients predicted...
Supplementary Figure 1. (Top) Venn Diagram showing the intersect between Hypoxia-M V2 significant DM...
Supplementary Figure 4 (Top). CD8 T cell enrichment is prognostic for Overall Survival (OS), local r...
Biomarkers with relevance for loco-regional therapy are needed in human papillomavirus negative aka ...
BACKGROUND Tumor hypoxia is a paradigmatic negative prognosticator of treatment resistance in Hea...
Clarifying the epigenetic regulation of tumor-related genes (TRGs) can provide insights into the mec...
<p>(A) Kaplan-Meier survival plots: (i) HPV (+) HNSCC tumors showing better survival compared to HPV...
PurposeThe hypoxic tumor microenvironment was reported to be involved in different tumorigenesis mec...
Supplementary Table S3. Distribution of clinical and biomarker-related characteristics between Methy...
Supplementary Table S7. Distribution of clinical and biomarker-related characteristics between Methy...
Supplementary Table S1. Multivariate Analysis for the Hypoxia-M and Brooks signature.</p
Supplementary Table S2. Treatment Information for the validation cohort (n=88, DKTK-ROG)</p
Supplementary Table S6. Contingency Table of Hypoxia-M and CD8-immunohistochemistry (IHC) staining f...
Supplementary Table S4. Correlations with CIBERSORT immune signature expressions in the TCGA-HNSCC c...
Supplementary Figure S3. (Top) Hypoxia-M V2 is associated with decreased OS in the TCGApancancer coh...
Supplementary Figure S2. (Top) Hypoxia-M V2 is prognostic in the DKTK-ROG cohort. Patients predicted...
Supplementary Figure 1. (Top) Venn Diagram showing the intersect between Hypoxia-M V2 significant DM...
Supplementary Figure 4 (Top). CD8 T cell enrichment is prognostic for Overall Survival (OS), local r...
Biomarkers with relevance for loco-regional therapy are needed in human papillomavirus negative aka ...
BACKGROUND Tumor hypoxia is a paradigmatic negative prognosticator of treatment resistance in Hea...
Clarifying the epigenetic regulation of tumor-related genes (TRGs) can provide insights into the mec...
<p>(A) Kaplan-Meier survival plots: (i) HPV (+) HNSCC tumors showing better survival compared to HPV...
PurposeThe hypoxic tumor microenvironment was reported to be involved in different tumorigenesis mec...